Possible stem cell origin of human cholangiocarcinoma

World J Gastroenterol. 2004 Nov 15;10(22):3374-6. doi: 10.3748/wjg.v10.i22.3374.

Abstract

Aim: To investigate the expression of CD34 and c-kit (receptor of stem cell factor) in cholangiocarcinoma.

Methods: Fifteen cases of intrahepatic cholangiocarcinoma and 17 cases of extrahepatic cholangiocarcinoma were studied in this experiment. Using Envision detection system, paraffin-embedded sections of the resected cholangiocarcinoma tissue were stained with antibodies against CD34 and c-kit, respectively. The sections were counterstained with hematoxylin, and the results were examined under light microscope. Normal tonsil and mammary tissues were used as positive controls for CD34 and c-kit, respectively.

Results: CD34 was positive in all sections, but only in capillary endothelial cells of tumor tissue. No cholangiocarcinoma cells were positive for CD34. In one case of extrahepatic cholangiocarcinoma, a few tumor cells (about 5%) were immunoreactive with c-kit.

Conclusion: CD34 or c-kit positive cells in liver tissue may represent liver stem cells, as they can differentiate into mature biliary cells in vitro. The expression of c-kit by some cholangiocarcinoma cells suggests that cholangiocarcinoma might originate from liver stem cells. However, other mechanisms of hepatocarcinogenesis, such as de-differentiation of mature cholangiocytes, may also exist.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antigens, CD34 / metabolism
  • Bile Duct Neoplasms / pathology*
  • Bile Ducts, Intrahepatic / pathology*
  • Cholangiocarcinoma / pathology*
  • Endothelial Cells / metabolism
  • Endothelial Cells / pathology
  • Female
  • Humans
  • Liver / pathology
  • Male
  • Middle Aged
  • Proto-Oncogene Proteins c-kit / metabolism
  • Stem Cells / pathology*

Substances

  • Antigens, CD34
  • Proto-Oncogene Proteins c-kit